eldecalcitol Report issue

Small molecule Experimental
AACT DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Eldecalcitol is an analog of calcitriol, the active form of vitamin D.   Wikipedia

Chemistry

  • SMILES: C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)[C@@H](OCCCO)[C@@H]1O
  • InChIKey: FZEXGDDBXLBRTD-AYIMTCTASA-N
  • Mol. Mass: 490.73
  • ALogP: 5.08
  • ChEMBL Molecule:
    eldecalcitol  
More Chemistry

Pharmacology

Alternative names

1α,25-dihydroxy-2β-(3-hydroxypropoxy)cholecalciferol | 20-epi-1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin d3 | 20-epi-ed-71 | 20-epi-eldecalcitol | 2-(3-hydroxypropoxy)-1,25-dihydroxyvitamin d3 | 2-(3-hydroxypropoxy)calcitriol | 9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol, 2-(3-hydroxypropoxy)-, (1alpha,2beta,3beta,5z,7e)- | ed 71 | ed-71 | eldecalcitol

Organizations (7)

Research & Development (7)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (4)

Approved Indications (1)


 

Osteoporosis

Experimental Indications - Clinical Trial Phases 1-4 (4)


 

Bone Diseases, Metabolic (Phase 4)

Healthy Volunteers (Phase 1)

Osteoporosis (Phase 3)

Osteoporosis, Postmenopausal (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial Organizations: 7

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue